CEO - Dror Chevion, gives Keynote speech and awarded Health 2.0 Outstanding Leadership Award (Dubai)
CEO Dror Chevion gave a KEYNOTE speech at the Health 2.0 Conference which attempts to reimagine the realm of healthcare by uniting some...
Events . News . Articles
The Feed
Search
- Jan 30
- 2 min
"First-In-Man Clinical Trial – Zygosid-50 for treating T2D" - summary of results (partial)
The primary efficacy objective of the study was to demonstrate that treatment with Zygosid-50 yields a significant reduction in the...
- Aug 5, 2021
- 2 min
First Patient Dosed in Clinical Trial!
Glucometer
- May 24, 2021
- 1 min
Our CLINICAL TRIAL is now Recruiting Type 2 Diabetes Patients
Concenter Biopharma, together with the SHEBA Medical Center in Israel recently began recruiting patients for the clinical trial using the...
- May 2, 2021
- 1 min
WINNERS OF THE 2021 BIOTECHNOLOGY AWARDS
Concenter BioPharma chosen as WINNERS OF THE 2021 BIOTECHNOLOGY AWARDS
- Mar 7, 2021
- 1 min
"Zycords" – Patent GRANTED by EPO!
The ZYCORDS patent was recently granted by the European Patent Office and was validated in major European countries.